Chicago, May 26, 2009
ProCure Treatment Centers, Inc., (ProCure) has selected Elekta to
provide workflow enhancing software and treatment planning
systems for its second IBA-equipped proton therapy center, which
is under construction in suburban Chicago. ProCure collaborates
with radiation oncology practices and hospitals to build and
operate proton therapy centers.
Supporting the entire workflow, the solutions – which include
the image-enabled oncology information system (OIS), MOSAIQ®, as
well as XiO® treatment planning system – will enable the
facility to treat patients in a chartless, paperless
environment.
Workflow optimization achieved through centralized information
management
In clinical use at four proton therapy facilities worldwide,
MOSAIQ provides centers with a sophisticated treatment
management solution that streamlines radiation therapy planning,
setup, verification, delivery review and analysis.
“With MOSAIQ, Elekta brings significant proton therapy and
radiation oncology expertise,” says Niek Schreuder, Senior Vice
President of Medical Physics and Technology at ProCure Treatment
Centers. “More importantly, Elekta shares ProCure’s vision of
making the OIS the central hub of the entire therapy workflow.”
Site to benefit from quick, accurate treatment plans
A comprehensive treatment planning system that combines the
latest tools and most robust dose calculation algorithms, XiO
allows users to generate quick and accurate treatment plans.
Developed more than a decade ago, XiO for protons is in clinical
use at more proton facilities than any other commercial vendor.
Vendor-neutral, XiO also is used in conjunction with IBA, Varian
and Mitsubishi delivery systems.
“Because of their proven track record, ease of use and
commitment to future enhancements, ProCure selected the Elekta
systems for our suburban Chicago facility,” adds Schreuder.
“We’re very pleased with the MOSAIQ and XiO systems currently
installed in our Training and Development Center, as well as our
soon-to-be opened Oklahoma center and we look forward to a
continued relationship with Elekta.”
“With a shared vision to deliver clinical advances for improved
patient care, Elekta is delighted and proud to continue working
with ProCure,” says Stewart Pegrum, Particle Therapy Business
Unit Manager for Elekta.
About Elekta
Elekta
is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The
company develops sophisticated state of the art tools and
treatment planning systems for radiation therapy and
radiosurgery, as well as workflow enhancing software systems
across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer
confidence to both healthcare providers and patients, Elekta
aims to improve, prolong and even save patient lives, making the
future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in
over 5,000 hospitals globally, and every day more than 100,000
patients receive diagnosis, treatment or follow-up with the help
of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. For more
information about Elekta, visit
elekta.com.
About ProCure Treatment Centers, Inc.
ProCure Treatment Centers, Inc., based in Bloomington, Ind., was
founded in 2005 to improve the lives of patients with cancer by
increasing access to proton therapy. ProCure collaborates with
leading radiation oncology practices and hospitals and provides
management leadership and a comprehensive approach for the
design, construction, financing, staffing, training and
day-to-day operations of world-class proton therapy centers.
ProCure’s solution reduces the time, cost and effort necessary
to create a facility. ProCure is the only company in the world
with two proton therapy centers under construction and two
others in development. ProCure’s Training and Development Center
is the first facility in the world dedicated to proton therapy.
For more information, visit
www.ProCure.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
Investor inquiries:
Lena Schattauer,
Investor Relations,
Elekta AB
Tel: +46 8 587 257 22, +46 70 595 51 00,
lena.schattauer@elekta.com
Link Disclaimer
|
